Team:Oxford/P&P intellectual property1
From 2014.igem.org
(Difference between revisions)
Line 64: | Line 64: | ||
</div> | </div> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
Line 122: | Line 128: | ||
+ | <style type="text/css"> | ||
+ | #ip_quote | ||
+ | { | ||
+ | margin-top:10px; | ||
+ | margin-bottom:10px; | ||
+ | margin-left:auto; | ||
+ | margin-right:auto; | ||
+ | width:auto; | ||
+ | color:#021E6B; | ||
+ | font-size:120%; | ||
+ | line-height:120%; | ||
+ | text-align:justify; | ||
+ | } | ||
+ | </style> | ||
+ | </html> | ||
+ | |||
+ | <div class="whitebox"> | ||
+ | |||
+ | __NOTOC__ | ||
+ | |||
+ | <div class="white_news_block"> | ||
+ | <html> | ||
+ | <center><a href="https://static.igem.org/mediawiki/2014/3/39/OxiGEM_Public_Survey.pdf">CLICK HERE TO DOWNLOAD A COPY OF OUR INTELLECTUAL PROPERTY SURVEY IN PDF FORMAT</a></p></center> | ||
+ | </html> | ||
+ | <div class="whitebox"> | ||
+ | |||
+ | <html> | ||
+ | <!-- BEGIN TIMELINE WHITEBOX HERE --> | ||
+ | <div name="zfhistory"> | ||
+ | <div id="timeline"> | ||
+ | |||
+ | <ul id="dates"> | ||
+ | |||
+ | <li><a href="#" class="dateobject">- 1 -</a></li> | ||
+ | |||
+ | <li><a href="#" class="dateobject">- 2 -</a></li> | ||
+ | |||
+ | <li><a href="#" class="dateobject">- 3 -</a></li> | ||
+ | |||
+ | <li><a href="#" class="dateobject">- 4 -</a></li> | ||
+ | |||
+ | <li><a href="#" class="dateobject">- 5 -</a></li> | ||
+ | |||
+ | <li><a href="#" class="dateobject">- 6 -</a></li> | ||
+ | |||
+ | <li><a href="#" class="dateobject">- 7 -</a></li> | ||
+ | |||
+ | </ul> | ||
+ | |||
+ | <ul id="issues"> | ||
+ | |||
+ | <li id="#- 1 -"> | ||
+ | |||
+ | <center><img src="https://static.igem.org/mediawiki/2014/5/5d/Experience_Chart.jpg" width="670" height="283" /></center> | ||
+ | |||
+ | <div class="issuedate">What is your primary source of information about synthetic biology?</div> | ||
+ | |||
+ | <p>As we can see, </p> | ||
+ | |||
+ | </li> | ||
+ | |||
+ | <li id="#- 2 -"> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2014/a/a0/Application_Chart.jpg" width="670" height="283" /> | ||
+ | |||
+ | <div class="issuedate">How would you rate the quality of this information?</div> | ||
+ | |||
+ | <p>The respondents rated information highly for accuracy (although perhaps this is to be expected as it is unlikely one would continue to read information from a source which regularly got the facts wrong). Relevance also scored highly, showing that people feel synthetic biology has a sufficient impact on their lives that they ought to be kept informed about it. The high score for availability is likely due to the heavy reliance on online information, however it is probable that this reliance also contributes to the relatively low scores for independence and accessibility. The sources accessed by the public online may well not be aimed at laymen but intended to be read by students or professionals and so may contain a high level of technical detail not accessible to the lay public.</p> | ||
+ | |||
+ | </li> | ||
+ | |||
+ | <li id="- 3 -"> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2014/c/ce/Commercial_Viability_Chart.jpg" width="480" height="283" /> | ||
+ | |||
+ | <p> <br>The majority of teams (85%) appear to feel that there is at least the possibility that their project could be turned into a viable business or project – this makes sense given that many teams seek to use their project as an opportunity to use synthetic biology to address a problem. </p> | ||
+ | |||
+ | </li> | ||
+ | |||
+ | <li id="#- 4 -"> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2014/c/cf/OxiGEMBenefit_to_Society.jpg" width="373" height="280" /> | ||
+ | |||
+ | <p>Again this chart shows how few teams believe their project is relevant to society. There was a split, slightly skewed towards commercial investment, in terms of the favoured means of funding, although it should be noted that many participants selected more than one option, suggesting mixed feelings and uncertainty on this question. Donation to the public domain was a popular option, indicating that many students support the BioBrick agreement and are keen to contribute their parts to it. </p> | ||
+ | |||
+ | </li> | ||
+ | |||
+ | <li id="#- 5 -"> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2014/6/6c/OxiGEMIP_UNderstanding.jpg" width="405" height="280" /> | ||
+ | |||
+ | |||
+ | <p>Responses to this question support the need for guidance for iGEM teams on IP issues. Possible explanations for this the larger than expected (29%) group selecting 'adequate' include: evidence of a Drunning-Kruger effect whereby people overestimate their level of knowledge; underestimating the significance and relevance of intellectual property law to synthetic biology; or a genuinely adequate understanding amongst students. </p> | ||
+ | |||
+ | </li> | ||
+ | |||
+ | <li id="#- 6 -"> | ||
+ | |||
+ | <center><img src="https://static.igem.org/mediawiki/2014/2/20/Patentability_Views_Graph.jpg" width="685" height="287" /></center> | ||
+ | |||
+ | </li> | ||
+ | |||
+ | <li id="#- 7 -"> | ||
+ | |||
+ | <center><img src="https://static.igem.org/mediawiki/2014/d/d2/OxigemPriorities_Chart.jpg" width="500" height="287" /></center> | ||
+ | <p> <br> The graph below shows that profit is the least important considerations to students, but all others ranked more or less equally overall. The most important factor overall was benefit to society.</p> | ||
+ | |||
+ | |||
+ | </li> | ||
+ | |||
+ | </ul> | ||
+ | |||
+ | <div id="grad_left"></div> | ||
+ | |||
+ | <div id="grad_right"></div> | ||
+ | |||
+ | <a href="#" id="next">+</a> | ||
+ | |||
+ | <a href="#" id="prev">-</a> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | |||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <!-- END TIMELINE WHITEBOX HERE --> | ||
+ | </div> | ||
Revision as of 23:34, 10 October 2014